TNF-Inhibition in the Treatment of Rheumatoid Arthritis

Larry W. Moreland, Paul Emery (Herausgeber)

Buch | Softcover

192 Seiten

2004
CRC Press (Verlag)
978-1-84184-156-4 (ISBN)

Titel ist leider vergriffen;
keine Neuauflage

Artikel merken

This book charts the history and development of the concept of TNF - an inhibition from its discovery in the laboratory to its clinical applications in the treatment of patients with rheumatoid arthritis.

The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of Rheumatoid Arthritis charts the history and development of the concept of TNFa inhibition. The authors document TNFa from its discovery to its now well-documented clinical applications in the treatment of patients with RA. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source containing the most recent information in this field.

Definition of TNFa as a Therapeutic Target for Rheumatoid Arthritis, M. Feldman, F.M. Brennan, R.O. Williams, and R.N. Maini
Infliximab Therapy, R.N. Maini and M. Feldman
Etanercept, S.Sule and J.M. Bathan
Adalimumab, L. van de Putte, J. Salfeld, and S. Kaymakcalan
p-55 TNF Receptor Therapy, J.J. Cash
TNFa-Inhibition in Practical Management of Rheumatoid Arthritis: The US Model, J.C. Shanahan and L.W. Moreland
TNFa-inhibition in Practical Management: The UK/European Model, P. Emery
Safety Issues with Anti-TNF Agents: Immunomodulation and Infection, J.C. Shanahan
Index

Erscheint lt. Verlag	4.1.2004
Zusatzinfo	90 Illustrations, black and white
Verlagsort	London
Sprache	englisch
Maße	140 x 210 mm
Gewicht	363 g
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie
ISBN-10	1-84184-156-0 / 1841841560
ISBN-13	978-1-84184-156-4 / 9781841841564
Zustand	Neuware